J.F.R. Robertson

Research interests

Publications

• Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

  The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(21)00288-6

• Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

  The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30777-5

• Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers

  Oncogene · 2006 · https://doi.org/10.1038/sj.onc.1209985

• Prognostic markers in triple‐negative breast cancer

  Cancer · 2006 · https://doi.org/10.1002/cncr.22381

• A gene-expression signature to predict survival in breast cancer across independent data sets

  Oncogene · 2006 · https://doi.org/10.1038/sj.onc.1209920

• High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

  International Journal of Cancer · 2005 · https://doi.org/10.1002/ijc.21004

• Fulvestrant, Formerly ICI 182,780, Is as Effective as Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing After Prior Endocrine Treatment

  Journal of Clinical Oncology · 2002 · https://doi.org/10.1200/jco.2002.10.057

• Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study

  Journal of Clinical Oncology · 2000 · https://doi.org/10.1200/jco.2000.18.22.3748

Current projects

No projects listed.